Ocular Therapeutix (OCUL) Tops Q3 EPS by 11c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.39), $0.11 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $477 thousand versus the consensus estimate of $470 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM